HEMOCUE AB – Trademark Portfolio

Entity Type: 03

HEMOCUE AB holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HEMOCUE. The owner is based in 262 23 ANGELHOLM.

BOX 1204

262 23 ANGELHOLM , SE

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HEMOCUE AB's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HEMOCUE AB have?

HEMOCUE AB has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.

What trademark classes does HEMOCUE AB file in?

HEMOCUE AB files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are HEMOCUE AB's most well-known trademarks?

HEMOCUE AB's registered trademark portfolio includes well-known marks such as HEMOCUE. These are among 2 currently registered trademarks in the portfolio.

What is HEMOCUE AB's trademark registration success rate?

HEMOCUE AB has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.